3 Recruiting Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Phase 1 Clinical Trials
Active phase 1 studies for clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 enrolling across the USA. Verify eligibility and contact site coordinators.
All Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 studiesPhase 1 Studies for Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
🔵 Active, Not Recruiting Phase1
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer
📍 Los Angeles General Medical Center — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔ 🟢 Recruiting Phase1
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔